Citi initiates coverage of Maze Therapeutics with Buy rating
Go back to Citi initiates coverage of Maze Therapeutics with Buy rating| (NASDAQ: MAZE) | Delayed: 29.29 +0.91 (3.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.38 | 52 Week High | $ | |||
| Open | $28.30 | 52 Week Low | $ | |||
| Day High | $29.47 | P/E | N/A | |||
| Day Low | $28.00 | EPS | $ | |||
| Volume | 158,957 | |||||
